title: Physical activity, high-sensitivity C-reactive protein, and total and cardiovascular disease mortality in type 2 diabetes.
abstract: OBJECTIVE
  Physical activity reduces high-sensitivity C-reactive protein (hs-CRP), cardiovascular disease (CVD), and total mortality in type 2 diabetic patients. However, it is not known whether the effects of physical activity on mortality depend on the levels of hs-CRP in patients with type 2 diabetes.
  
  
  METHODS
  We prospectively followed-up on 569 type 2 diabetic patients, aged 45-64 years, who were free of CVD at baseline. Participants were stratified according to the level of hs-CRP (<1.0, 1.0-3.0, or >3.0 mg/L) and the degree of physical activity (0-4 metabolic equivalent tasks [METs] or >4 METs). The Cox proportional hazards model was used to estimate the joint association between physical activity and hs-CRP levels and the risk of mortality.
  
  
  RESULTS
  During an 18-year follow-up, 356 patients died, 217 of whom died of CVD. Those who were physically more active had significantly reduced total, CVD and coronary heart disease (CHD) mortality among patients with elevated hs-CRP levels (>3 mg/L). These findings persisted in multivariable analyses. However, in patients with an hs-CRP level<1 mg/L or between 1 and 3 mg/L, there was no statistically significant relationship between physical activity and CVD or CHD mortality.
  
  
  CONCLUSIONS
  Physical activity reduces total, CVD, and CHD mortality in type 2 diabetic patients with elevated hs-CRP levels. This suggests that the anti-inflammatory effect of physical activity may counteract increased CVD and CHD morbidity and mortality associated with high CRP levels.
authors: Department of Medicine, University of Turku and Turku University Hospital, Turku, Finland. tkveps@utu.fi
authors: Teemu
authors: T
authors: Vepsäläinen
authors: Minna
authors: M
authors: Soinio
authors: Jukka
authors: J
authors: Marniemi
authors: Seppo
authors: S
authors: Lehto
authors: Auni
authors: A
authors: Juutilainen
authors: Markku
authors: M
authors: Laakso
authors: Tapani
authors: T
authors: Rönnemaa
references: Diabetes Care. 1988 Jun;11(6):449-63
references: 3402300
references: Diabetes Care. 2006 Feb;29(2):329-33
references: 16443882
references: N Engl J Med. 1997 Apr 3;336(14):973-9
references: 9077376
references: Stroke. 1981 Mar-Apr;12(2 Pt 2 Suppl 1):I13-44
references: 7222164
references: Circulation. 1999 Jul 6;100(1):96-102
references: 10393687
references: J Am Coll Cardiol. 2005 Sep 20;46(6):1112-3
references: 16168299
references: Circulation. 2003 Jan 28;107(3):499-511
references: 12551878
references: Am J Pathol. 2001 Mar;158(3):1039-51
references: 11238052
references: J Physiol. 1999 Feb 15;515 ( Pt 1):287-91
references: 9925898
references: Eur Heart J. 2005 Oct;26(19):2018-25
references: 15987707
references: Circulation. 2000 Jul 4;102(1):42-7
references: 10880413
references: N Engl J Med. 1999 Jan 14;340(2):115-26
references: 9887164
references: Diabetologia. 2010 Sep;53(9):1886-9
references: 20526577
references: N Engl J Med. 1998 Jul 23;339(4):229-34
references: 9673301
references: Clin Sci (Lond). 1991 Nov;81(5):677-83
references: 1721863
references: J Physiol. 1998 May 1;508 ( Pt 3):949-53
references: 9518745
references: Nutr Metab Cardiovasc Dis. 2010 Oct;20(8):608-17
references: 19695853
references: Am J Med. 2004 Oct 1;117(7):499-507
references: 15464707
references: N Engl J Med. 2001 Jun 28;344(26):1959-65
references: 11430324
references: J Am Coll Cardiol. 2005 May 17;45(10):1563-9
references: 15893167
references: Atherosclerosis. 2004 Sep;176(1):173-9
references: 15306191
references: Anal Biochem. 1977 Aug;81(2):485-7
references: 907113